EU pharma policy: choosing between industry and health
19 October 2009
Ian Schofield
Please Login to read the full article.
19 October 2009
Ian Schofield
ian.schofield@informa.com
Why is policy on pharmaceuticals and medical devices managed by the European Commission's industry directorate at EU level, while in the member states it is governed by health departments? It's a question that has often been asked but never fully answered.
Responsibility for the EU legislation...
Please Login to read the full article.
RELATED CONTENT
NEWS
- US Capitol Capsule: IOM focus on affordable 'essential' benefits expected to stir debate on drug prices
- How to ride the second Chinese biosimilar wave
- FDA's Hamburg declares no one can "inspect world on its own" for poor quality medicines
- US Capitol Capsule: Obama seeks to secure global supply chain; reveals new plan
COMMENT
Other Informa Comment
EVENTS
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
26 March 2012
Copenhagen, Denmark
JOB OF THE WEEK
Promote your vacancy here
